BPC-157

Pentadecapeptide BPC 157; Body Protection Compound-157; bepecin

Identity

Sequence

GEPPPGKPADDAGLV

Three-letter

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Length

15 residues

Modifications

None (free acid)

Formula

C62H98N16O22

Average mass

1419.5 Da

CAS

137525-51-7

Specifications (per released lot)

Purity

≥ 98 % by RP-HPLC, 220 nm

Identity

ESI-MS; observed mass within 0.1 % of calculated

Form

White to off-white lyophilized powder

Counter-ion

Trifluoroacetate; acetate on request

Net peptide content

Reported per lot (typically 70–90 % of gross mass; the balance is counter-ion and water)

Vial sizes

5 mg · 10 mg · 25 mg net peptide; bulk on quotation

Storage

−20 °C, desiccated, protected from light. Ships at ambient temperature.

Documents

Lot certificate of analysis (COA library); safety data sheet in WHMIS 2015 format, enclosed with every shipment

Research context

Synthetic 15-residue fragment of a sequence found in human gastric-juice protein. Used in preclinical models of gastrointestinal, tendon, ligament and skeletal-muscle injury, and in nitric-oxide and angiogenesis pathway studies.

Literature context is provided to help laboratories identify the reagent. It is not a claim about effects in people and does not describe any use outside in-vitro or approved animal research.